Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1974 Oct;30(4):312–318. doi: 10.1038/bjc.1974.198

Delayed Cutaneous Hypersensitivity Reactions in Patients With Kaposi's Sarcoma

J F Taylor, J L Ziegler
PMCID: PMC2009295  PMID: 4447775

Abstract

Defects in cellular immunocompetence have been sought in 25 patients with Kaposi's sarcoma. Skin tests with recall antigens, and PHA lymphocyte stimulation in vitro showed that efferent delayed hypersensitivity responses are intact in the majority. However, attempted sensitization and subsequent challenge with DNCB demonstrated that the afferent limb of the responses was impaired in some patients. This did not appear to be related to the morphology of the tumour or to prognosis.

Tumour specific reactions were demonstrated both in vivo and in vitro and these correlated significantly with the morphology and histology. The interpretation of the results for an individual is confounded by the multiplicity of factors influencing the outcome in a particular patient.

Full text

PDF
312

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dobozy A., Husz S., Hunyadi J., Berkó G., Simon N. Immune deficiencies and Kaposi's sarcoma. Lancet. 1973 Sep 15;2(7829):625–625. doi: 10.1016/s0140-6736(73)92465-3. [DOI] [PubMed] [Google Scholar]
  2. Fass L., Herberman R. B., Ziegler J. Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells. N Engl J Med. 1970 Apr 2;282(14):776–780. doi: 10.1056/NEJM197004022821404. [DOI] [PubMed] [Google Scholar]
  3. Giraldo G., Beth E., Haguenau F. Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst. 1972 Dec;49(6):1509–1526. doi: 10.1093/jnci/49.6.1509. [DOI] [PubMed] [Google Scholar]
  4. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  5. Master S. P., Taylor J. F., Kyalwazi S. K., Ziegler J. L. Immunological studies in Kaposi's sarcoma in Uganda. Br Med J. 1970 Mar 7;1(5696):600–602. doi: 10.1136/bmj.1.5696.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Reynolds W. A., Winkelmann R. K., Soule E. H. Kaposi's sarcoma: a clinicopathologic study with particular reference to its relationship to the reticuloendothelial system. Medicine (Baltimore) 1965 Sep;44(5):419–443. doi: 10.1097/00005792-196509000-00003. [DOI] [PubMed] [Google Scholar]
  7. Siegel J. H., Janis R., Alper J. C., Schutte H., Robbins L., Blaufox M. D. Disseminated visceral Kaposi's sarcoma. Appearance after human renal homograft operation. JAMA. 1969 Feb 24;207(8):1493–1496. [PubMed] [Google Scholar]
  8. Solowey A. C., Rapaport F. T. Immunologic responses in cancer patients. Surg Gynecol Obstet. 1965 Oct;121(4):756–760. [PubMed] [Google Scholar]
  9. Taylor J. F., Junge U., Wolff L., Deinhardt F., Kyalwazi S. K. Lymphocyte transformation in patients with Kaposi's sarcoma. Int J Cancer. 1971 Nov 15;8(3):468–474. doi: 10.1002/ijc.2910080315. [DOI] [PubMed] [Google Scholar]
  10. Vogel C. L., Templeton C. J., Templeton A. C., Taylor J. F., Kyalwazi S. K. Treatment of Kaposi's sarcoma with actinomycin-D and cyclophosphamide: results of a randomized clinical trial. Int J Cancer. 1971 Jul 15;8(1):136–143. doi: 10.1002/ijc.2910080117. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES